Medicare Enrolled
Dr. Mohammad Farra, MD
Critical Care Medicine · Farmington Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Farra from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farra?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Farra
Dr. Mohammad Farra is a critical care medicine specialist in Farmington Hills, MI, with 21 years of NPI registration. Based on federal Medicare data, Dr. Farra performed 3,571 Medicare services across 2,198 unique beneficiaries.
Between the years covered by Open Payments, Dr. Farra received a total of $19,121 from 56 pharmaceutical and/or device companies across 747 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Farra is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 3% volume in MI
$19,121 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,571
Medicare services
Top 3% in MI for critical care medicine
2,198
Unique beneficiaries
$69
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~170 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
828 | $94 | $175 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
487 | $64 | $110 |
| Therapeutic respiratory procedure, 15 minutes A one-on-one, face-to-face therapeutic procedure designed to improve respiratory function. The session includes monitoring and is billed per 15 minutes. |
388 | $8 | $20 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
252 | $44 | $125 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
249 | $41 | $125 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
246 | $67 | $120 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
194 | $173 | $450 |
| Group respiratory therapy Therapeutic exercises designed to improve respiratory function or increase the strength and endurance of respiratory muscles. The session involves two or more individuals and includes monitoring. |
158 | $10 | $30 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
132 | $20 | $75 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
128 | $29 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
112 | $126 | $225 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
87 | $95 | $150 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
81 | $140 | $270 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
64 | $139 | $225 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
40 | $45 | $375 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
29 | $118 | $300 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
26 | $100 | $500 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
24 | $23 | $475 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
16 | $197 | $600 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
15 | $47 | $150 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $99 | $225 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$19,121
Total received (2018-2024)
Avg $2,732/year across 7 years
Top 9% in MI for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
747
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,557 (86.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,563 (13.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,641
2023
$2,873
2022
$2,492
2021
$2,477
2020
$1,922
2019
$2,068
2018
$2,648
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$2,563
AstraZeneca Pharmaceuticals LP
$599
GlaxoSmithKline, LLC.
$292
Inari Medical, Inc.
$170
Inspire Medical Systems, Inc.
$141
Janssen Pharmaceuticals, Inc
$110
Boehringer Ingelheim Pharmaceuticals, Inc.
$107
Mylan Specialty L.P.
$103
United Therapeutics Corporation
$66
Insmed, Inc.
$65
GENZYME CORPORATION
$59
Amgen Inc.
$59
Regeneron Healthcare Solutions, Inc.
$52
Merck Sharp & Dohme LLC
$44
ANI Pharmaceuticals, Inc.
$44
CSL Behring
$43
Gilead Sciences, Inc.
$41
Edwards Lifesciences Corporation
$26
Mallinckrodt Hospital Products Inc.
$19
Novo Nordisk Inc
$19
ZOLL Respicardia, Inc.
$17
Top 3 companies account for 74.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,977
INTUITIVE SURGICAL, INC.
$2,563
AstraZeneca Pharmaceuticals LP
$2,260
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,208
Mylan Specialty L.P.
$1,332
GENZYME CORPORATION
$859
United Therapeutics Corporation
$705
Regeneron Healthcare Solutions, Inc.
$463
Grifols USA, LLC
$458
Bard Access Systems, Inc.
$368
Actelion Pharmaceuticals US, Inc.
$358
Insmed, Inc.
$339
Sunovion Pharmaceuticals Inc.
$330
Pulmonx Corporation
$314
Axsome Therapeutics, Inc.
$274
CSL Behring
$267
Gilead Sciences, Inc.
$266
Circassia Pharmaceuticals Inc
$255
Janssen Pharmaceuticals, Inc
$253
Amgen Inc.
$225
Inspire Medical Systems, Inc.
$179
Electromed, Inc.
$170
Inari Medical, Inc.
$170
PORTOLA PHARMACEUTICALS, INC.
$120
Mallinckrodt Enterprises LLC
$117
Mallinckrodt LLC
$104
Mallinckrodt Hospital Products Inc.
$92
Becton, Dickinson and Company
$88
Teva Pharmaceuticals USA, Inc.
$84
E.R. Squibb & Sons, L.L.C.
$79
Genentech USA, Inc.
$69
Philips Electronics North America Corporation
$63
Maquet Cardiovascular U.S. Sales, L.L.C.
$63
Paratek Pharmaceuticals, Inc.
$61
Merck Sharp & Dohme LLC
$58
Takeda Pharmaceuticals U.S.A., Inc.
$57
Merck Sharp & Dohme Corporation
$52
ANI Pharmaceuticals, Inc.
$44
Harmony Biosciences LLC
$41
PFIZER INC.
$37
Inogen, Inc.
$33
Advanced Respiratory, Inc
$28
Edwards Lifesciences Corporation
$26
Veran Medical Technologies, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$19
Novo Nordisk Inc
$19
ZOLL Respicardia, Inc.
$17
Covis Pharma GmBH
$17
Jazz Pharmaceuticals Inc.
$16
JAZZ PHARMACEUTICALS INC.
$16
Vapotherm Inc
$16
Shire North American Group Inc
$16
Cumberland Pharmaceuticals, Inc.
$16
ARBOR PHARMACEUTICALS, INC.
$15
Ultragenyx Pharmaceutical Inc.
$14
ADVANCED RESPIRATORY, INC
$11
Top 3 companies account for 40.8% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CARDIOHELP · CHARTIS CATHETER · CINQAIR · CT THROMBECTOMY SYSTEM KIT · Crysvita · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Da Vinci Surgical System · ELIQUIS · Esbriet · FASENRA · GLASSIA · HemoSphere · Horizant · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · KEYTRUDA · Kcentra · LONHALA MAGNAIR · Letairis · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PAXLOVID · POWER TRIALYSIS · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · Pulmonx Endobronchial Valve EBV · QVAR · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Spin · Sunosi · TAGRISSO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · VAPOTHERM · Veklury · Vibativ · Wakix · XARELTO · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for critical care medicine in MI.
Geographic Context
Critical care medicines within 10 mi
103
Per 100K population
8.1
County median income
$95,296
Nearest hospital
BEAUMONT HOSPITAL - FARMINGTON HILLS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Farra is a clinical cardiology specialist, with above-average Medicare volume (top 3% in MI), with low-engagement industry engagement in the top 9% of MI peers, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Farra experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Farra performed 828 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farra receive payments from pharmaceutical companies?
Yes. Dr. Farra received a total of $19,121 from 56 companies across 747 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farra's costs compare to other critical care medicines in Farmington Hills?
Dr. Farra's average Medicare payment per service is $69. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farra) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Farmington Hills
Browse critical care medicines in Farmington Hills ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in MI
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in MI
Which MI critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology